LFCR FY 2024 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$267M

FY 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$128M+24.2% YoY

Gross Profit

$42M32.6% margin

Operating Income

-$9M-6.9% margin

Net Income

$12M9.4% margin

EPS (Diluted)

$0.33

Cash Flow

Operating Cash Flow

$257,000

Free Cash Flow

-$18M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$254M

Total Liabilities

$243M

Stockholders' Equity

$11M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$128M	$103M	+24.2%
Gross Profit	$42M	$28M	+49.5%
Operating Income	-$9M	-$22M	+59.4%
Net Income	$12M	-$100M	+112.1%